Check if trademark MENTRANRIX is available

USPTO Filing History

Key events recorded for this trademark application

2007-05-22 — Application filed
2007-05-25 — Application filed
2007-08-28 — Assigned to examiner
2007-08-29 — Suspension letter written
2007-08-29 — Notification of letter of suspension e-mailed
2007-08-29 — Letter of suspension e-mailed
2008-02-29 — Assigned to lie
2008-02-29 — Suspension checked - to attorney for action
2008-03-03 — Suspension inquiry written
2008-03-03 — Inquiry to suspension e-mailed
2008-03-03 — Notification of inquiry as to suspension e-mailed
2008-08-26 — Teas response to suspension inquiry received
2008-08-26 — Teas/email correspondence entered
2008-08-26 — Correspondence received in law office
2008-09-04 — Data modification completed
2008-09-04 — Approved for pub - principal register
2008-09-13 — Law office publication review completed
2008-10-01 — Notice of publication
2008-10-21 — Published for opposition
2009-01-06 — Registered-principal register
2009-11-18 — Attorney/dom.rep.revoked and/or appointed
2009-11-18 — Teas revoke/app/change addr of atty/dom rep received
2010-05-13 — Teas change of correspondence received
2013-02-20 — Attorney/dom.rep.revoked and/or appointed
2013-02-20 — Teas revoke/app/change addr of atty/dom rep received
2013-03-15 — Teas change of correspondence received
2013-06-07 — Attorney/dom.rep.revoked and/or appointed
2013-06-07 — Teas revoke/app/change addr of atty/dom rep received
2015-06-08 — Teas change of correspondence received
2015-08-07 — Cancelled sec. 8 (6-yr)
2015-08-07 — Final status recorded

Owner Information

GlaxoSmithKline Biologicals S.A.
Rixensart BE

Correspondent

Angela L. Wilson GlaxoSmithKline
Five Moore Drive
Legal Global Trademarks, Mailstop: 5.5A
Research Triangle Park, NC 27709-0183

Filing Details

Filing Date:
2007-05-22

Status Date:
2015-08-07

Category:
Pharmaceuticals

Filing Year:
2007